Site icon Eminence Papers

Juvenile Idiopathic Arthritis (JIA)

Juvenile Idiopathic Arthritis (JIA)

JIA is an autoimmune condition where synovitis persists for at least six weeks in children who are below sixteen years of age. It is depicted by persistent inflammation of the synovial membrane with infiltration of lymphocytes and macrophages into the synovial membrane, leading to synovial hypertrophy, pannus formation, and progressive joint destruction. Pathophysiology consists of increased levels of cytokines such as interleukin one, interleukin six, and tumor necrosis factor-alpha, which are responsible for triggering systemic and joint symptoms. Chronic inflammation causes cartilage destruction, bone deformation, and impaired further development (Thatayatikom et al., 2023).

JIA presents with symptoms such as joint pain, edema, joint warmth, and morning stiffness involving the knees, wrists, and ankles in an oligoarticular or polyarticular manner. Rare systemic manifestations observed in the onset of systemic JIA are fever, hepatosplenomegaly, lymphadenopathy, and a transient salmon-colored rash. Some of the key diagnostic measures include heightened erythrocyte sedimentation rate, increased C-reactive protein levels, positive antinuclear antibody test, and signs of synovitis and joint effusion on ultrasound or magnetic resonance imaging. Management plans are aimed at controlling pain inflammation, preventing joint destruction, and maintaining functionality by using corticosteroids, disease-modifying antirheumatic drugs, and non-steroidal anti-inflammatory medications. Timely diagnosis with proper immunosuppressive treatment are the critical determinants that may control further disease progression and musculoskeletal status (NIAMS, 2024).

Diversity, equity, and inclusion in JIA care means eradicating bias in the availability of pediatric rheumatologic services and interventions for children with the condition. According to Swihart et al. (2023), cultural competence in the provision of care recognizes impediments such as language, beliefs, and economic status that should not affect early diagnosis or compliance with treatment plans. Incorporating interpreters, community outreach, and comprehensive care teams enhances equal patient opportunity for treatment and improves their health outcomes. Diversity, equity, and inclusion frameworks also support diversity in clinical research and strengthen health education diversity. Incorporating diversity, equity, and inclusion promotes holistic patient care and management of JIA in children, irrespective of their demographic background (Martinez et al., 2024).

References

Martinez, R. M., Taffe, R., & Alper, J. (2024, April 1). The history, evolution, and impact of diversity, equity, and inclusion and health equity in health organizations and systems, public health, and government. Exploring Diversity, Equity, Inclusion, and Health Equity Commitments and Approaches by Health Organization C-Suites – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK603467/

NIAMS. (2024, July 24). Juvenile idiopathic arthritis (JIA). National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/juvenile-arthritis

Swihart, D. L., Martin, R. L., & Yarrarapu, S. N. S. (2023). Cultural religious competence in clinical practice. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493216/

Thatayatikom, A., Modica, R., & De Leucio, A. (2023, January 16). Juvenile idiopathic arthritis. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK554605

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

Question 


Juvenile Idiopathic Arthritis (JIA)

Musculoskeletal Disorders

Choose a musculoskeletal disorder from the text that impacts children.

Juvenile Idiopathic Arthritis (JIA)

Juvenile Idiopathic Arthritis (JIA)

Define the condition.
Address key points of pathophysiology clinical manifestation and evaluation and treatment. Use appropriate physiological terms in your response.
How can diversity, equity and inclusion be fostered in functionally debilitating musculoskeletal conditions affecting children?
Provide 4 evidence-based references to support your content.
one page paper no header needed
4 references
citations after every paragraph
APA 7 format

Exit mobile version